New project funded

Together, Thomas L. Mindt and his cooperation-partners Wolfgang Kandioller (University of Vienna) and Berthold Nock (Demokritos, Athens) received a grant by the Austrian Science Fund for the new project on “Metabolically Stabilized Peptidomimetics for Improved Tumour Targeting”. Go and read more about the project..

New Podcast – Epigenetic Biomarkers in Cancer

This podcast with Professor Gerda Egger (Department of Pathology, Medical University of Vienna and Ludwig Boltzmann Institute Applied Diagnostics) provides an overview of the current routinely used biomarkers as well as an outlook on what is on the horizon in epigenetic biomarkers.

park hyatt vienna

2nd DONAU SYMPOSIUM – including the CBmed Biomarker Conference

The 2nd “Danube Symposium” meeting, together with the 3rd CBmed Biomarker Conference, intended to provide a forum to open-minded experts both from academia and industry in the field of molecular pathology, laboratory medicine, nuclear medicine, clinical pharmacology and beyond who share this vision and like to engage in advancing effective and individualized treatments based on […]

33rd International Austrian Winter Symposium – Radioactive Isotopes in Molecular Imaging

24th – 27th January 2018, the LBI:AD was part of the 33rd International Austrian Winter Symposium that was organized by the Austrian Society of Nuclear Medicine & Molecular Imaging  together with the 13th ALPE ADRIA Nuclear Medicine Symposium. Traditionally, the scientific event was supported by the wonderful atmosphere of Zell am See, Austria.An intriguing start […]

Johannes Längle – Posterpreis – 34th annual meeting Austrian Society of Surgical Oncology

(Wien, 17-10-2017) Johannes Längle von der Klinischen Abteilung für Allgemeinchirurgie der Universitätsklinik für Chirurgie der MedUni Wien/AKH Wien wurde bei der diesjährigen 34. Jahrestagung der Österreichische Gesellschaft für Chirurgische Onkologie (ACO-ASSO) mit einem Posterpreis ausgezeichnet.Die Studie hatte den Titel „DNA damage, DNA sensor DDX41 and ER stress response predict prognosis and treatment response in colorectal […]

Der LBG Weinherbst 2017

Beim LBG Weinherbst am 11. Oktober 2017 stellte die Ludwig Boltzmann Gesellschaft zwei Forschungsgruppen vor, die sich mit der psychischen Gesundheit von Kindern mit psychisch erkrankten Eltern befassen werden. Die international und interdisziplinär – von Psychologie über Computer- bis Theaterwissenschaften – besetzten Teams haben sich in einem “Ideas Lab” formiert und ihre Konzepte für die […]

AGRR2017

Nathalie Grob – AGRR 2017 award for the best presentation

Ms. Mag. Nathalie Grob, who is currently a Ph.D. student (ETH Zurich and Paul Scherrer Institut in Villigen (CH)) of LBI:AD key researcher Prof. Mindt, won at the 25th annual meeting of the “Arbeitsgemeinschaft Radiochemie/ Radiopharmazie” in Starnberg, Germany, the AGRR-2017 award for the best presentation in the category young researcher. She presented her research […]

Thomas Dillinger – 13th YSA PhD Symposium

This year’s PhD Symposium of the Young Scientist Association (YSA) took place on the 8th and 9th of June at the Medical University of Vienna. We are very proud to announce that the poster “Identification of Biomarkers for prostate cancer by DNA methylation analysis” of our PhD Student Thomas Dillinger, MSc won the award for […]

12th OGNMB Congress 18 – 20 January 2017

For the third time since 2013, the national meeting of OGNMB was held in the modern Ferry Porsche Congress Centre (FPCC) in Zell am See. Due to the great success in the recent years, the focus of the congress was on interdisciplinary sessions jointly organized by nuclear physicians, physicists, radiopharmacists and radiological technologists.During two and […]

First Board of Partners Meeting

On the 21th December 2016, the LBI Applied Diagnostics held its first Board of Partners Meeting in the famous Viennese Adolf Looshaus with a subsequent historical tour. Happily, all partners were represented physically or via dial-in possibility. Therefore, important decisions about the future of the institute could be made. We are happy to announce that […]